164 related articles for article (PubMed ID: 35253188)
1. Ultrasound-guided wire localization biopsy in non-palpable breast lesions: predictive factors for malignancy.
Yilmaz S; Ünal GK; Aslan HS; Değirmencioğlu S; Aykota MR
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1320-1327. PubMed ID: 35253188
[TBL] [Abstract][Full Text] [Related]
2. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
[TBL] [Abstract][Full Text] [Related]
3. Patent blue and air as an alternative for resection of nonpalpable breast lesions: a case series.
Vieira SC; Alves VC; Oliveira TC; Ibiapina JO; Soares EC; Crisanto ML
Sao Paulo Med J; 2014; 132(1):10-4. PubMed ID: 24474074
[TBL] [Abstract][Full Text] [Related]
4. An audit of the results of ultrasound-guided core needle biopsy of mammography versus ultrasound screen-detected breast lesions.
Rhee SJ; Han BK; Ko ES; Choi JS; Ko EY
J Clin Ultrasound; 2017 Jun; 45(5):261-266. PubMed ID: 28182285
[TBL] [Abstract][Full Text] [Related]
5. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A
Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.
Dobrosavljević A; Rakić S; Nikoli B; Raznatović SJ; Dikić SD; Milosević Z; Jurisić A; Skrobić M
Vojnosanit Pregl; 2016 Mar; 73(3):239-45. PubMed ID: 27295907
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.
Tonegutti M; Girardi V
Radiol Med; 2008 Feb; 113(1):65-75. PubMed ID: 18338128
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
[TBL] [Abstract][Full Text] [Related]
10. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
[TBL] [Abstract][Full Text] [Related]
11. A Five-Year Review of the Outcomes of Breast Imaging Reporting and Data System 4 Lesions in Hospital Universiti Sains Malaysia.
Marthay K; Yahya MM; Tengku Din TADA; Wan Zain WZ; Haron J; Wong MP; Ramely R; Wan Mokhter WMM; Hashim Isa Merican SR; Mohd Hashim MN
Cureus; 2022 Mar; 14(3):e22757. PubMed ID: 35371885
[TBL] [Abstract][Full Text] [Related]
12. Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)?
Bednarova I; Londero V; Linda A; Girometti R; Lorenzon M; Bednarova S; Zuiani C
Radiol Med; 2018 Nov; 123(11):809-817. PubMed ID: 29974332
[TBL] [Abstract][Full Text] [Related]
13. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of adjunctive ultrasound-guided diffuse optical tomography in women undergoing breast biopsy: Impact on BI-RADS assessments.
Poplack SP; Young CA; Hagemann IS; Luo J; Herman CR; Wiele K; Li S; Zeng Y; Covington MF; Zhu Q
Eur J Radiol; 2021 Dec; 145():110029. PubMed ID: 34801874
[TBL] [Abstract][Full Text] [Related]
15. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy.
Bérubé M; Curpen B; Ugolini P; Lalonde L; Ouimet-Oliva D
Can Assoc Radiol J; 1998 Aug; 49(4):223-8. PubMed ID: 9709675
[TBL] [Abstract][Full Text] [Related]
16. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
[TBL] [Abstract][Full Text] [Related]
17. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
[TBL] [Abstract][Full Text] [Related]
18. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
19. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
Ball CG; Butchart M; MacFarlane JK
Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
[TBL] [Abstract][Full Text] [Related]
20. BI-RADS categorization as a predictor of malignancy.
Orel SG; Kay N; Reynolds C; Sullivan DC
Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
